Dr Janet Scott

  • Clinical Lecturer in Infectious Diseases (Centre for Virus Research)

Biography

Dr Janet Scott is Clinical Lecturer in Infectious Disease at the MRC-University of Glasgow Centre for Virus Research.

Dr Scott trained in Parasitology at the University of Glasgow and holds a PhD in the cellular immune-epidemiology of Schistosomiasis, also from the University of Glasgow, with research in The Gambia, Zimbabwe and Senegal.

After gaining a degree in Medicine at the University of Oxford, she joined the TB Vaccine team as a clinical academic in parallel with her clinical training.

During the Ebola 2014-16 epidemic, she was the clinical lead for the Brincidofovir Trial (Monrovia, Liberia), and Convalescent Plasma (Freetown, Sierra Leone) and was also a member of the clinical trial team for the Tekmira trial.

She is now engaged in the pharmacokinetic/pharmacodynamics analysis of data gathered during these trials and developing methods for dose optimizing drugs for category 4 viruses and studying post Ebola and post COVID syndromes.

Research interests

Virus image CVR Supporting COVID-19 Research Response

CVR logo

 

Dr Scott's main interests are: post viral sequalae focusing on 'LongCOVID' and Post Ebola Syndrome targeting particularly post viral fatigue.

She is also interested in optimising the doses of anti-viral therapeutics using pharmacokinetic and pharmacodynamic in vitro and in silico models with a focus for Lassa and Ebola viruses.

 

Selected Media

  • Voice of America podcast with Joe De Capua discussing Ebola and research stating that 80 per cent of survivors suffer disabilities one year after being discharged from hospital.

Listen here: https://soundcloud.com/post-ebola-syndrome  

  • BBC World Service audio documentary discussing whether the Ebola Virus can live on undetected (9 October 2015).

Listen here (06:43-11:35): http://www.bbc.co.uk/p0343hb5  

  • BBC News Hour show discussing if WHO declaring the Ebola epidemic officially over was really the good news the region had been waiting for with flare-ups likely (14 January 2016)

Listen here: http://www.bbc.co.uk/programmes/p03fgzv8

Publications

List by: Type | Date

Jump to: 2021 | 2020 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2008 | 2007 | 2004 | 2003 | 2001 | 2000 | 1998
Number of items: 46.

2021

Carson, G. and Long Covid Forum Group, (2021) Research priorities for Long Covid: refined through an international multi-stakeholder forum. BMC Medicine, 19(1), 84. (doi: 10.1186/s12916-021-01947-0) (PMID:33785027) (PMCID:PMC8009733)

Sigfrid, L. et al. (2021) What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? A harmonised, global longitudinal observational study protocol. BMJ Open, 11(3), e043887. (doi: 10.1136/bmjopen-2020-043887) (PMID:33692181) (PMCID:PMC7948153)

Adaken, C. et al. (2021) Ebola virus antibody decay–stimulation in a high proportion of survivors. Nature, 590, pp. 468-472. (doi: 10.1038/s41586-020-03146-y) (PMID:33505020) (PMCID:PMC7839293)

Munblit, D. et al. (2021) The risk of overlooking children during the COVID-19 pandemic: Paediatric Long-COVID may be a ticking time bomb. Lancet Child and Adolescent Health, (Accepted for Publication)

2020

Hanna, C. R. et al. (2020) Glasgow Early Treatment Arm Favirpiravir (GETAFIX) for adults with early stage COVID-19: A structured summary of a study protocol for a randomised controlled trial. Trials, 21(935), (doi: 10.1186/s13063-020-04891-1) (PMID:33213530) (PMCID:PMC7675389)

Knight, S. R. et al. (2020) Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score. British Medical Journal, 2020, 370. (doi: 10.1136/bmj.m3339) (PMID:32907855)

Swann, O. V. et al. (2020) Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study. British Medical Journal, 370, m3249. (doi: 10.1136/bmj.m3249) (PMID:32960186) (PMCID:PMC7488201)

Holgate, S. et al. (2020) Preparing for a challenging winter 2020/21. Technical Report. Academy of Medical Sciences, London.

Harrison, E. M. et al. (2020) Ethnicity and outcomes from COVID-19: the ISARIC CCP-UK prospective observational cohort study of hospitalised patients. SSRN Electronic Journal, (doi: 10.2139/ssrn.3618215) (Submitted)

Akhvlediani, T. et al. (2020) Global outbreak research: harmony not hegemony. Lancet Infectious Diseases, 20(7), pp. 770-772. (doi: 10.1016/S1473-3099(20)30440-0) (PMID:32502433) (PMCID:PMC7266570)

Docherty, A. B. et al. (2020) Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. British Medical Journal, 369, m1985. (doi: 10.1136/bmj.m1985) (PMID:32444460)

Scott, J. T. , Sharma, R., Meredith, L. W., Dunning, J., Moore, C. E., Sahr, F., Ward, S., Goodfellow, I. and Horby, P. (2020) Pharmacokinetics of TKM-130803 in Sierra Leonean patients with Ebola virus disease: plasma concentrations exceed target levels, with drug accumulation in the most severe patients. EBioMedicine, 52, 102601. (doi: 10.1016/j.ebiom.2019.102601) (PMID:31953031) (PMCID:PMC7033524)

2018

Howlett, P. J. et al. (2018) Case series of severe neurologic sequelae of Ebola virus disease during epidemic, Sierra Leone. Emerging Infectious Diseases, 24(8), pp. 1412-1421. (doi: 10.3201/eid2408.171367) (PMID:30014839)

Steptoe, P. J. et al. (2018) Multimodal imaging and spatial analysis of Ebola retinal lesions in 14 survivors of Ebola virus disease. JAMA Ophthalmology, 136(6), pp. 689-693. (doi: 10.1001/jamaophthalmol.2018.1248) (PMID:29800941)

Tedder, R. S. et al. (2018) Detection, characterization, and enrollment of donors of Ebola convalescent plasma in Sierra Leone. Transfusion, 58(5), pp. 1289-1298. (doi: 10.1111/trf.14580) (PMID:29572862) (PMCID:PMC5947131)

Jagadesh, S., Fletcher, T. E., Sevalie, S., Weigel, R. and Scott, J. T. (2018) Reply to Steptoe et al. Clinical Infectious Diseases, 66(8), p. 1319. (doi: 10.1093/cid/cix980) (PMID:29126296)

Steptoe, P. J., Scott, J. T. , Sahr, F., Vandy, M., Harding, S. P., Beare, N. A. V. and Semple, M. G. (2018) Re: Shantha et al.: Ophthalmic manifestations and causes of vision impairment in Ebola virus disease survivors in Monrovia, Liberia (Ophthalmology. 2017;124:170-177). Ophthalmology, 125(3), e19. (doi: 10.1016/j.ophtha.2017.09.009) (PMID:29458832)

Jagadesh, S., Sevalie, S., Fatoma, R., Sesay, F., Sahr, F., Faragher, B., Semple, M. G., Fletcher, T. E., Weigel, R. and Scott, J. T. (2018) Disability among Ebola survivors and their close contacts in Sierra Leone: a retrospective case-controlled cohort study. Clinical Infectious Diseases, 66(1), pp. 131-133. (doi: 10.1093/cid/cix705) (PMID:29020205) (PMCID:PMC5833946)

2017

Steptoe, P. J., Scott, J. T. and Semple, M. G. (2017) Reply to Lee and colleagues—Viral posterior uveitis. Survey of Ophthalmology, 62(4), pp. 404-445. (doi: 10.1016/j.survophthal.2016.12.008) (PMID:28624250)

Steptoe, P. J., Scott, J. T. , Harding, S. P., Beare, N. A. V., Semple, M. G., Vandy, M. J. and Sahr, F. (2017) Ocular complications in survivors of the Ebola outbreak in Guinea. American Journal of Ophthalmology, 181, p. 180. (doi: 10.1016/j.ajo.2017.05.029) (PMID:28760310) (PMCID:PMC5833943)

Steptoe, P. J. et al. (2017) Novel retinal lesion in Ebola survivors, Sierra Leone, 2016. Emerging Infectious Diseases, 23(7), pp. 1102-1109. (doi: 10.3201/eid2307.161608) (PMID:28628441) (PMCID:PMC5512503)

Glynn, J. R. et al. (2017) Asymptomatic infection and unrecognised Ebola virus disease in Ebola-affected households in Sierra Leone: a cross-sectional study using a new non-invasive assay for antibodies to Ebola virus. Lancet Infectious Diseases, 17(6), pp. 645-653. (doi: 10.1016/S1473-3099(17)30111-1) (PMID:28256310)

Scott, J. T. and Semple, M. G. (2017) Ebola virus disease sequelae: a challenge that is not going away. Lancet Infectious Diseases, 17(5), pp. 470-471. (doi: 10.1016/S1473-3099(17)30027-0) (PMID:28094207) (PMCID:PMC5818139)

Howlett, P., Walder, A., Lisk, D., N'jai, A., Lado, M., Brown, C., Sevalie, S., Sesay, F.R., Semple, M.G. and Scott, J.T. (2017) Neurological and Psychiatric Manifestations of Post Ebola Syndrome in Sierra Leone. Spring Meeting for Clinician Scientists in Training 2017, London, UK, 23 Feb 2017. S48. (doi:10.1016/S0140-6736(17)30444-0)

2016

Glod, J. W. et al. (2016) Experimental treatment of Ebola virus disease with brincidofovir. PLoS ONE, 11(9), e0162199. (doi: 10.1371/journal.pone.0162199) (PMID:27611077) (PMCID:PMC5017617)

Bustinduy, A. L. et al. (2016) Population pharmacokinetics and pharmacodynamics of praziquantel in Ugandan children with intestinal schistosomiasis: higher dosages are required for maximal efficacy. mBio, 7(4), e00227-16. (doi: 10.1128/mBio.00227-16) (PMID:27507822) (PMCID:PMC4992966)

Burki, T. K., Crozier, I., Lado, M. and Scott, J. (2016) Post-Ebola syndrome. Lancet Infectious Diseases, 16(7), pp. 780-781. (doi: 10.1016/S1473-3099(15)00259-5) (PMID:27352759)

Scott, J. T. , Sesay, F. R., Massaquoi, T. A., Idriss, B. R., Sahr, F. and Semple, M. G. (2016) Post-Ebola syndrome, Sierra Leone. Emerging Infectious Diseases, 22(4), pp. 641-646. (doi: 10.3201/eid2204.151302) (PMID:26983037) (PMCID:PMC4806950)

Scott, J. T. (2016) Ebola epidemic over but flare-ups likely. [Audio]

2015

Scott, J. T. (2015) Can the Ebola virus live on undetected? [Audio]

2014

Bustinduy, A., King, C., Scott, J. , Appleton, S., Sousa-Figueiredo, J. C., Betson, M. and Stothard, J. R. (2014) HIV and schistosomiasis co-infection in African children. Lancet Infectious Diseases, 14(7), pp. 640-649. (doi: 10.1016/S1473-3099(14)70001-5) (PMID:24747019)

2013

Rowland, R. et al. (2013) Safety and immunogenicity of an FP9-vectored candidate tuberculosis vaccine (FP85A), alone and with candidate vaccine MVA85A in BCG-vaccinated healthy adults. Human Vaccines and Immunotherapeutics, 9(1), pp. 50-62. (doi: 10.4161/hv.22464) (PMID:23143773) (PMCID:PMC3667946)

2012

Scott, J. T. , Scally, C., Peden, N. and Macleod, M. (2012) Voltage-gated potassium channel antibody-related encephalopathy: a case which may extend the documented phenotype of this condition. BMJ Case Reports, 2012, 0720114476. (doi: 10.1136/bcr.07.2011.4476) (PMID:22693327) (PMCID:PMC4543178)

2008

Scott, J. (2008) Should I apply for an academic foundation programme? Foundation Years, 4(2), pp. 85-86. (doi: 10.1016/j.mpfou.2008.03.002)

2007

Vereecken, K., Naus, C. W. A., Polman, K., Scott, J. T. , Diop, M., Gryseels, B. and Kestens, L. (2007) Associations between specific antibody responses and resistance to reinfection in a Senegalese population recently exposed to Schistosoma mansoni. Tropical Medicine and International Health, 12(3), pp. 431-444. (doi: 10.1111/j.1365-3156.2006.01805.x) (PMID:17313515)

2004

Debacker, M., Aguiar, J., Steunou, C., Zinsou, C., Meyers, W. M., Scott, J. T. , Dramaix, M. and Portaels, F. (2004) Mycobacterium ulcerans disease: role of age and gender in incidence and morbidity. Tropical Medicine and International Health, 9(12), pp. 1297-1304. (doi: 10.1111/j.1365-3156.2004.01339.x) (PMID:15598261)

Debacker, M., Aguiar, J., Steunou, C., Zinsou, C., Meyers, W. M., Guédénon, A., Scott, J. T. , Dramaix, M. and Portaels, F. (2004) Mycobacterium ulcerans Disease (Buruli Ulcer) in Rural Hospital, Southern Benin, 1997–2001. Emerging Infectious Diseases, 10(8), pp. 1391-1398. (doi: 10.3201/eid1008.030886) (PMID:15496239) (PMCID:PMC3320395)

Chatterjee, S., Mbaye, A., Alfidja, A. T., Weyler, J., Scott, J. T. , Van Damme, P., Van De Vijver, K., Deelder, A. and Van Marck, E. A.E. (2004) Circulating levels of the neuropeptide hormone somatostatin may determine hepatic fibrosis in Schistosoma mansoni infections. Acta Tropica, 90(2), pp. 191-203. (doi: 10.1016/j.actatropica.2003.12.002) (PMID:15177146)

Scott, J. T. , Johnson, R. C., Aguiar, J., Debacker, M., Kestens, L., Guedenon, A., Gryseels, B. and Portaels, F. (2004) Schistosoma haematobium infection and Buruli ulcer. Emerging Infectious Diseases, 10(3), pp. 551-552. (doi: 10.3201/eid1003.020514) (PMID:15116714) (PMCID:PMC3322796)

Scott, J. T. , Vereecken, K., Diakhate, M. M., Vanagt, T., Sambou, V., Diop, M., Ly, A., Vercruysse, J., Gryseels, B. and Kestens, L. (2004) Are the cellular immune responses of children and adults with Schistosoma mansoni infection intrinsically different? Cytokines produced ex vivo in response to antigens and mitogens. Parasite Immunology, 26(1), pp. 29-36. (doi: 10.1111/j.0141-9838.2004.00680.x) (PMID:15198643)

2003

Mduluza, T. et al. (2003) Contrasting cellular responses in Schistosoma haematobium infected and exposed individuals from areas of high and low transmission in Zimbabwe. Immunology Letters, 88(3), pp. 249-256. (doi: 10.1016/S0165-2478(03)00088-9) (PMID:12941484)

Scott, J.T. et al. (2003) Corrigendum. Tropical Medicine and International Health, 8(6), p. 580. (doi: 10.1046/j.1365-3156.2003.01068.x)

Scott, J.T. et al. (2003) Human water contacts patterns in Schistosoma mansoni epidemic foci in northern Senegal change according to age, sex and place of residence, but are not related to intensity of infection. Tropical Medicine and International Health, 8(2), pp. 100-108. (doi: 10.1046/j.1365-3156.2003.00993.x) (PMID:12581433)

2001

Scott, J. T. , Turner, C.M. R., Mutapi, F., Woolhouse, M. E.J., Ndhlovu, P. D. and Hagan, P. (2001) Cytokine responses to mitogen and Schistosoma haematobium antigens are different in children with distinct infection histories. Parasite Immunology, 23(10), pp. 519-526. (doi: 10.1046/j.1365-3024.2001.00409.x) (PMID:11696162)

2000

Scott, J. T. , Turner, C. M. R., Mutapi, F., Woolhouse, M. E.J., Chandiwana, S. K., Mduluza, T., Ndhlovu, P. D. and Hagan, P. (2000) Dissociation of interleukin-4 and interleukin-5 production following treatment for Schistosoma haematobium infection in humans. Parasite Immunology, 22(7), pp. 341-348. (doi: 10.1046/j.1365-3024.2000.00311.x) (PMID:10886718)

1998

Mutapi, F., Ndhlovu, P. D., Hagan, P., Spicer, J. T. , Mduluza, T., Turner, C. M. R., Chandiwana, S. K. and Woolhouse, M. E.J. (1998) Chemotherapy accelerates the development of acquired immune responses to Schistosoma haematobium infection. Journal of Infectious Diseases, 178(1), pp. 289-293. (doi: 10.1086/517456) (PMID:9652458)

This list was generated on Sun Apr 18 18:51:41 2021 BST.
Number of items: 46.

Articles

Carson, G. and Long Covid Forum Group, (2021) Research priorities for Long Covid: refined through an international multi-stakeholder forum. BMC Medicine, 19(1), 84. (doi: 10.1186/s12916-021-01947-0) (PMID:33785027) (PMCID:PMC8009733)

Sigfrid, L. et al. (2021) What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? A harmonised, global longitudinal observational study protocol. BMJ Open, 11(3), e043887. (doi: 10.1136/bmjopen-2020-043887) (PMID:33692181) (PMCID:PMC7948153)

Adaken, C. et al. (2021) Ebola virus antibody decay–stimulation in a high proportion of survivors. Nature, 590, pp. 468-472. (doi: 10.1038/s41586-020-03146-y) (PMID:33505020) (PMCID:PMC7839293)

Munblit, D. et al. (2021) The risk of overlooking children during the COVID-19 pandemic: Paediatric Long-COVID may be a ticking time bomb. Lancet Child and Adolescent Health, (Accepted for Publication)

Hanna, C. R. et al. (2020) Glasgow Early Treatment Arm Favirpiravir (GETAFIX) for adults with early stage COVID-19: A structured summary of a study protocol for a randomised controlled trial. Trials, 21(935), (doi: 10.1186/s13063-020-04891-1) (PMID:33213530) (PMCID:PMC7675389)

Knight, S. R. et al. (2020) Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score. British Medical Journal, 2020, 370. (doi: 10.1136/bmj.m3339) (PMID:32907855)

Swann, O. V. et al. (2020) Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study. British Medical Journal, 370, m3249. (doi: 10.1136/bmj.m3249) (PMID:32960186) (PMCID:PMC7488201)

Harrison, E. M. et al. (2020) Ethnicity and outcomes from COVID-19: the ISARIC CCP-UK prospective observational cohort study of hospitalised patients. SSRN Electronic Journal, (doi: 10.2139/ssrn.3618215) (Submitted)

Akhvlediani, T. et al. (2020) Global outbreak research: harmony not hegemony. Lancet Infectious Diseases, 20(7), pp. 770-772. (doi: 10.1016/S1473-3099(20)30440-0) (PMID:32502433) (PMCID:PMC7266570)

Docherty, A. B. et al. (2020) Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. British Medical Journal, 369, m1985. (doi: 10.1136/bmj.m1985) (PMID:32444460)

Scott, J. T. , Sharma, R., Meredith, L. W., Dunning, J., Moore, C. E., Sahr, F., Ward, S., Goodfellow, I. and Horby, P. (2020) Pharmacokinetics of TKM-130803 in Sierra Leonean patients with Ebola virus disease: plasma concentrations exceed target levels, with drug accumulation in the most severe patients. EBioMedicine, 52, 102601. (doi: 10.1016/j.ebiom.2019.102601) (PMID:31953031) (PMCID:PMC7033524)

Howlett, P. J. et al. (2018) Case series of severe neurologic sequelae of Ebola virus disease during epidemic, Sierra Leone. Emerging Infectious Diseases, 24(8), pp. 1412-1421. (doi: 10.3201/eid2408.171367) (PMID:30014839)

Steptoe, P. J. et al. (2018) Multimodal imaging and spatial analysis of Ebola retinal lesions in 14 survivors of Ebola virus disease. JAMA Ophthalmology, 136(6), pp. 689-693. (doi: 10.1001/jamaophthalmol.2018.1248) (PMID:29800941)

Tedder, R. S. et al. (2018) Detection, characterization, and enrollment of donors of Ebola convalescent plasma in Sierra Leone. Transfusion, 58(5), pp. 1289-1298. (doi: 10.1111/trf.14580) (PMID:29572862) (PMCID:PMC5947131)

Jagadesh, S., Fletcher, T. E., Sevalie, S., Weigel, R. and Scott, J. T. (2018) Reply to Steptoe et al. Clinical Infectious Diseases, 66(8), p. 1319. (doi: 10.1093/cid/cix980) (PMID:29126296)

Steptoe, P. J., Scott, J. T. , Sahr, F., Vandy, M., Harding, S. P., Beare, N. A. V. and Semple, M. G. (2018) Re: Shantha et al.: Ophthalmic manifestations and causes of vision impairment in Ebola virus disease survivors in Monrovia, Liberia (Ophthalmology. 2017;124:170-177). Ophthalmology, 125(3), e19. (doi: 10.1016/j.ophtha.2017.09.009) (PMID:29458832)

Jagadesh, S., Sevalie, S., Fatoma, R., Sesay, F., Sahr, F., Faragher, B., Semple, M. G., Fletcher, T. E., Weigel, R. and Scott, J. T. (2018) Disability among Ebola survivors and their close contacts in Sierra Leone: a retrospective case-controlled cohort study. Clinical Infectious Diseases, 66(1), pp. 131-133. (doi: 10.1093/cid/cix705) (PMID:29020205) (PMCID:PMC5833946)

Steptoe, P. J., Scott, J. T. and Semple, M. G. (2017) Reply to Lee and colleagues—Viral posterior uveitis. Survey of Ophthalmology, 62(4), pp. 404-445. (doi: 10.1016/j.survophthal.2016.12.008) (PMID:28624250)

Steptoe, P. J., Scott, J. T. , Harding, S. P., Beare, N. A. V., Semple, M. G., Vandy, M. J. and Sahr, F. (2017) Ocular complications in survivors of the Ebola outbreak in Guinea. American Journal of Ophthalmology, 181, p. 180. (doi: 10.1016/j.ajo.2017.05.029) (PMID:28760310) (PMCID:PMC5833943)

Steptoe, P. J. et al. (2017) Novel retinal lesion in Ebola survivors, Sierra Leone, 2016. Emerging Infectious Diseases, 23(7), pp. 1102-1109. (doi: 10.3201/eid2307.161608) (PMID:28628441) (PMCID:PMC5512503)

Glynn, J. R. et al. (2017) Asymptomatic infection and unrecognised Ebola virus disease in Ebola-affected households in Sierra Leone: a cross-sectional study using a new non-invasive assay for antibodies to Ebola virus. Lancet Infectious Diseases, 17(6), pp. 645-653. (doi: 10.1016/S1473-3099(17)30111-1) (PMID:28256310)

Scott, J. T. and Semple, M. G. (2017) Ebola virus disease sequelae: a challenge that is not going away. Lancet Infectious Diseases, 17(5), pp. 470-471. (doi: 10.1016/S1473-3099(17)30027-0) (PMID:28094207) (PMCID:PMC5818139)

Glod, J. W. et al. (2016) Experimental treatment of Ebola virus disease with brincidofovir. PLoS ONE, 11(9), e0162199. (doi: 10.1371/journal.pone.0162199) (PMID:27611077) (PMCID:PMC5017617)

Bustinduy, A. L. et al. (2016) Population pharmacokinetics and pharmacodynamics of praziquantel in Ugandan children with intestinal schistosomiasis: higher dosages are required for maximal efficacy. mBio, 7(4), e00227-16. (doi: 10.1128/mBio.00227-16) (PMID:27507822) (PMCID:PMC4992966)

Burki, T. K., Crozier, I., Lado, M. and Scott, J. (2016) Post-Ebola syndrome. Lancet Infectious Diseases, 16(7), pp. 780-781. (doi: 10.1016/S1473-3099(15)00259-5) (PMID:27352759)

Scott, J. T. , Sesay, F. R., Massaquoi, T. A., Idriss, B. R., Sahr, F. and Semple, M. G. (2016) Post-Ebola syndrome, Sierra Leone. Emerging Infectious Diseases, 22(4), pp. 641-646. (doi: 10.3201/eid2204.151302) (PMID:26983037) (PMCID:PMC4806950)

Bustinduy, A., King, C., Scott, J. , Appleton, S., Sousa-Figueiredo, J. C., Betson, M. and Stothard, J. R. (2014) HIV and schistosomiasis co-infection in African children. Lancet Infectious Diseases, 14(7), pp. 640-649. (doi: 10.1016/S1473-3099(14)70001-5) (PMID:24747019)

Rowland, R. et al. (2013) Safety and immunogenicity of an FP9-vectored candidate tuberculosis vaccine (FP85A), alone and with candidate vaccine MVA85A in BCG-vaccinated healthy adults. Human Vaccines and Immunotherapeutics, 9(1), pp. 50-62. (doi: 10.4161/hv.22464) (PMID:23143773) (PMCID:PMC3667946)

Scott, J. T. , Scally, C., Peden, N. and Macleod, M. (2012) Voltage-gated potassium channel antibody-related encephalopathy: a case which may extend the documented phenotype of this condition. BMJ Case Reports, 2012, 0720114476. (doi: 10.1136/bcr.07.2011.4476) (PMID:22693327) (PMCID:PMC4543178)

Scott, J. (2008) Should I apply for an academic foundation programme? Foundation Years, 4(2), pp. 85-86. (doi: 10.1016/j.mpfou.2008.03.002)

Vereecken, K., Naus, C. W. A., Polman, K., Scott, J. T. , Diop, M., Gryseels, B. and Kestens, L. (2007) Associations between specific antibody responses and resistance to reinfection in a Senegalese population recently exposed to Schistosoma mansoni. Tropical Medicine and International Health, 12(3), pp. 431-444. (doi: 10.1111/j.1365-3156.2006.01805.x) (PMID:17313515)

Debacker, M., Aguiar, J., Steunou, C., Zinsou, C., Meyers, W. M., Scott, J. T. , Dramaix, M. and Portaels, F. (2004) Mycobacterium ulcerans disease: role of age and gender in incidence and morbidity. Tropical Medicine and International Health, 9(12), pp. 1297-1304. (doi: 10.1111/j.1365-3156.2004.01339.x) (PMID:15598261)

Debacker, M., Aguiar, J., Steunou, C., Zinsou, C., Meyers, W. M., Guédénon, A., Scott, J. T. , Dramaix, M. and Portaels, F. (2004) Mycobacterium ulcerans Disease (Buruli Ulcer) in Rural Hospital, Southern Benin, 1997–2001. Emerging Infectious Diseases, 10(8), pp. 1391-1398. (doi: 10.3201/eid1008.030886) (PMID:15496239) (PMCID:PMC3320395)

Chatterjee, S., Mbaye, A., Alfidja, A. T., Weyler, J., Scott, J. T. , Van Damme, P., Van De Vijver, K., Deelder, A. and Van Marck, E. A.E. (2004) Circulating levels of the neuropeptide hormone somatostatin may determine hepatic fibrosis in Schistosoma mansoni infections. Acta Tropica, 90(2), pp. 191-203. (doi: 10.1016/j.actatropica.2003.12.002) (PMID:15177146)

Scott, J. T. , Johnson, R. C., Aguiar, J., Debacker, M., Kestens, L., Guedenon, A., Gryseels, B. and Portaels, F. (2004) Schistosoma haematobium infection and Buruli ulcer. Emerging Infectious Diseases, 10(3), pp. 551-552. (doi: 10.3201/eid1003.020514) (PMID:15116714) (PMCID:PMC3322796)

Scott, J. T. , Vereecken, K., Diakhate, M. M., Vanagt, T., Sambou, V., Diop, M., Ly, A., Vercruysse, J., Gryseels, B. and Kestens, L. (2004) Are the cellular immune responses of children and adults with Schistosoma mansoni infection intrinsically different? Cytokines produced ex vivo in response to antigens and mitogens. Parasite Immunology, 26(1), pp. 29-36. (doi: 10.1111/j.0141-9838.2004.00680.x) (PMID:15198643)

Mduluza, T. et al. (2003) Contrasting cellular responses in Schistosoma haematobium infected and exposed individuals from areas of high and low transmission in Zimbabwe. Immunology Letters, 88(3), pp. 249-256. (doi: 10.1016/S0165-2478(03)00088-9) (PMID:12941484)

Scott, J.T. et al. (2003) Corrigendum. Tropical Medicine and International Health, 8(6), p. 580. (doi: 10.1046/j.1365-3156.2003.01068.x)

Scott, J.T. et al. (2003) Human water contacts patterns in Schistosoma mansoni epidemic foci in northern Senegal change according to age, sex and place of residence, but are not related to intensity of infection. Tropical Medicine and International Health, 8(2), pp. 100-108. (doi: 10.1046/j.1365-3156.2003.00993.x) (PMID:12581433)

Scott, J. T. , Turner, C.M. R., Mutapi, F., Woolhouse, M. E.J., Ndhlovu, P. D. and Hagan, P. (2001) Cytokine responses to mitogen and Schistosoma haematobium antigens are different in children with distinct infection histories. Parasite Immunology, 23(10), pp. 519-526. (doi: 10.1046/j.1365-3024.2001.00409.x) (PMID:11696162)

Scott, J. T. , Turner, C. M. R., Mutapi, F., Woolhouse, M. E.J., Chandiwana, S. K., Mduluza, T., Ndhlovu, P. D. and Hagan, P. (2000) Dissociation of interleukin-4 and interleukin-5 production following treatment for Schistosoma haematobium infection in humans. Parasite Immunology, 22(7), pp. 341-348. (doi: 10.1046/j.1365-3024.2000.00311.x) (PMID:10886718)

Mutapi, F., Ndhlovu, P. D., Hagan, P., Spicer, J. T. , Mduluza, T., Turner, C. M. R., Chandiwana, S. K. and Woolhouse, M. E.J. (1998) Chemotherapy accelerates the development of acquired immune responses to Schistosoma haematobium infection. Journal of Infectious Diseases, 178(1), pp. 289-293. (doi: 10.1086/517456) (PMID:9652458)

Research Reports or Papers

Holgate, S. et al. (2020) Preparing for a challenging winter 2020/21. Technical Report. Academy of Medical Sciences, London.

Conference or Workshop Item

Howlett, P., Walder, A., Lisk, D., N'jai, A., Lado, M., Brown, C., Sevalie, S., Sesay, F.R., Semple, M.G. and Scott, J.T. (2017) Neurological and Psychiatric Manifestations of Post Ebola Syndrome in Sierra Leone. Spring Meeting for Clinician Scientists in Training 2017, London, UK, 23 Feb 2017. S48. (doi:10.1016/S0140-6736(17)30444-0)

Audio

Scott, J. T. (2016) Ebola epidemic over but flare-ups likely. [Audio]

Scott, J. T. (2015) Can the Ebola virus live on undetected? [Audio]

This list was generated on Sun Apr 18 18:51:41 2021 BST.

Grants

Grants and Awards listed are those received whilst working with the University of Glasgow.

  • Glasgow Early Treatment Arm Favipiravir (GETAFIX): a randomised controlled study of favipiravir in COVID-19 hospitalised patients
    Chief Scientist Office
    2020 - 2021
     
  • Development of an in vitro system for dose and regimen optimisation of therapeutics for Lassa Fever
    Tenovus Scotland
    2018 - 2020
     

MRC, University of Glasgow and CVR logos